RENAISSANCE HEALTH CARE, INC. AWARDED HEALTH MANAGEMENT CORPORATION CONTRACT FOR DISEASE MANAGEMENT OF CHRONIC KIDNEY DISEASE

Lexington, MA – Renaissance Health Care, Inc. (Renaissance) today announced that it has been awarded a contract by Health Management Corporation (HMC) to provide disease management for HMC contracts with its parent corporation, WellPoint, Inc. and its members who suffer from chronic kidney disease. Renaissance is a National Committee for Quality Assurance (NCQA)-accredited disease management company providing specialized services to kidney patients. Renaissance has demonstrated unparalleled results in renal disease management on a national basis.

Robert Farrell, CEO of Renaissance, commented: “It is indeed an honor to have been chosen by HMC to provide chronic kidney disease management for its WellPoint participating members. HMC is a leading integrated care management company that recognizes the tremendous need to address the debilitating effects of end stage renal disease. We are pleased to begin working with HMC and expect to achieve positive results through our disease management program and to significantly benefit HMC’s contracted WellPoint participating members.”

About HMC
Founded in 1983, HMC is a leading integrated care management company addressing chronic and complex health conditions that have a dramatic impact on health care outcomes and costs. Through a combination of clinical interventions, innovative technology, advanced predictive models and rigorous evaluation methodology, HMC helps health plans and employers to increase self care, improve clinical outcomes and control overall costs. The company’s unique clinical structure consists of assigned primary nurse care managers, who develop an Individualized Intervention Plan® (IIP) to address participants’ primary and co-morbid conditions. HMC is consistently recognized by Health Industries Research Companies as one of the top disease management companies in America. For more information about HMC, call 800-523-9279 or visit www.choosehmc.com.

About Renaissance Health Care, Inc.
Renaissance Health Care, Inc. started in 1996, and is the leading provider of Disease Management services for patients with CKD. Renaissance is a National Committee for Quality Assurance (NCQA) accredited renal disease management company providing specialized services to kidney patients. Renaissance has a national network of nurse care managers and an expanding national base of customer contracts. For more information on Renaissance, visit www.usrenal.com. Renaissance Health Care, Inc. is a wholly owned subsidiary of Fresenius Medical Care North America (FMCNA), which is a subsidiary of Fresenius Medical Care AG & Co. KGaA (Frankfurt Stock Exchange: FME, FME3) (NYSE: FMS, FMS-p). For more information about Fresenius Medical Care visit the Company’s website at www.fmc-ag.com.

This release contains forward-looking statements that are subject to various risks and uncertainties. Actual results could differ materially from those described in these forward-looking statements due to certain factors, including changes in business, economic and competitive conditions, regulatory reforms, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. These and other risks and uncertainties are detailed in Fresenius Medical Care AG & Co. KGaA’'s reports filed with the U.S. Securities and Exchange Commission. Fresenius Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward-looking statements in this release.